Article Information
History
- August 3, 2022.
Article Versions
- Version 1 (July 29, 2022 - 16:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eric Lee1,2,
- Kevin Chern3,
- Michael Nissen4,
- Xuehai Wang4,
- IMAXT Consortium5,
- Chris Huang6,
- Anita K. Gandhi6,
- Alexandre Bouchard-Côté3,
- Andrew P. Weng4,7 and
- Andrew Roth1,7,8,*
- 1Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada
- 2Graduate Bioinformatics Training Program, University of British Columbia, Vancouver, BC, Canada
- 3Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada
- 4Terry Fox Laboratory, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
- 5CRUK IMAXT Grand Challenge Consortium, Cambridge, UK
- 6Translational Medicine Hematology, Bristol Myers Squibb, Summit NJ, USA
- 7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
- 8Department of Computer Science, University of British Columbia, Vancouver, British Columbia, Canada
- ↵*Correspondence should be addressed to AR (aroth{at}bccrc.ca)